Trade Policy Office Eyes Japan's Push to Make Novel Food a Strategic Industry with 1 Trillion Yen Investment

โดย InfoQuest·JPTHUS·Read original
Summary · why it matters

The Trade Policy and Strategy Office of the Ministry of Commerce disclosed that Japan has announced a draft long-term public and private investment plan through 2040, elevating the novel food industry to one of the country's strategic industries. This national plan aims to attract a total of more than 370 trillion yen, covering 17 strategic fields and 62 key products and technologies, ranging from artificial intelligence, semiconductors, quantum technology, biotechnology and clean energy to Food Tech, which is one of those 17 strategic fields. For the novel food industry specifically, Japan plans to allocate about 1 trillion yen in investment to push the market value to 3 trillion yen by 2040, from the current market value of 300 billion yen for alternative protein and 15 billion yen for functional foods. The government plans to establish a new budget category called Strong and Prosperous Japan with no spending ceiling and the ability to plan long-term budgets. Japan has chosen to build on its strengths in fermentation technology, functional foods and food formulation innovation rather than investing in cultivated meat, and has set a strategy to expand into the United States and Europe before entering Asian markets. Meanwhile, in 2025 Japan was Thailand's third-largest export market for agricultural and agro-industrial products, with export value of 5.08194 billion US dollars, or about 166.781 billion baht, although this was down 2.1% from the previous year. The director of the Trade Policy and Strategy Office stated that Japan's accelerated investment in the novel food industry is a golden opportunity for Thai operators to upgrade to become technology developers and producers of high-value food ingredients.

Theme Impact 1

Related news

United StatesCanada
▲

Maple Leaf Foods to Consolidate U.S. Plant Protein Production in Indianapolis

Maple Leaf Foods Inc. will consolidate its U.S. plant protein production into a single Centre of Excellence in Indianapolis, winding down its Seattle and Turners Falls plants in phases through the fourth quarter of 2027. The move is part of the company's Fuel for Growth initiative, which aims to simplify its manufacturing footprint, enhance efficiency and support its plant protein brands more competitively. The consolidation update sits alongside Maple Leaf's recent first-quarter 2026 results, which showed CA$962.85 million in sales and CA$46.07 million in net income. Maple Leaf's narrative projects CA$5.6 billion in revenue and CA$467.3 million in earnings by 2028, requiring 4.2% yearly revenue growth and an earnings increase of about CA$372.7 million from CA$94.6 million today. Two fair value estimates from the Simply Wall St Community span CA$35.90 to CA$83.26, against a CA$35.90 fair value estimate that implies 45% upside to the current price.
MFI
Synthetic Biology (non-pharma) ▲
About megatrends
Synthetic Biology (non-pharma) › Alt-Protein & Precision Fermentation ▲Supply
Maple Leaf Foods Inc. · Capital · Positive Consolidating U.S. plant protein production into one Indianapolis facility under the Fuel for Growth initiative to simplify its footprint and improve efficiency
Read original ↗
Simply Wall St·6hRead more →
CanadaUnited StatesGermany

Planet Based Foods Global Appoints Sagar Yadav and Stephanie Cook to Board

Planet Based Foods Global Inc. has appointed Sagar Yadav and Stephanie Cook to its Board of Directors, effective September 28, 2026. The company, which trades on the CSE under PBF, on OTC Pink under PBFFF and on the FSE under AZ00, said both directors will hold office until the next annual meeting or until their successor is elected or appointed. The Board welcomed the two appointees and said it looks forward to their contributions. Planet Based Foods Global describes itself as a developer of sustainable ingredients, plant-based solutions and agricultural technology. Kerem Akbas serves as Chairman of the Board, Chief Executive Officer and President.
China Grand Ph…Shanghai Henli…PBF
Synthetic Biology (non-pharma)
About megatrends
Synthetic Biology (non-pharma) › Alt-Protein & Precision Fermentation Talent
Planet Based Foods Global Inc. · Regulation · Neutral Board appointment of two directors is a governance matter with no clear positive or negative impact on the company.
Read original ↗
Newsfile Corp.·4dRead more →
China
▲

Angel Yeast Raises Phase II Investment in Baiyang Biotech Park to 1.061 Billion Yuan

Angel Yeast announced on September 24 that it has adjusted the Phase II project of the Baiyang Biotech Park implemented by its Yichang High-tech Zone subsidiary, raising the total investment from the original 797 million yuan to 1.061 billion yuan. The main purpose is to boost production capacity for annual yeast protein and co-products. The adjusted annual plan is for 12,000 tonnes of high-purity yeast protein and 32,000 tonnes of yeast protein and co-products. The project is expected to start construction within 2026, with an estimated return on investment of 10.74%. In the first half of 2026, Angel Yeast achieved revenue of 9.187 billion yuan and net profit attributable to the parent of 881 million yuan.
Angel Yeast Co… ▲
Synthetic Biology (non-pharma) ▲
About megatrends
Synthetic Biology (non-pharma) › Alt-Protein & Precision Fermentation ▲Supply
600298.CG · Capital · Positive Angel Yeast raises Phase II Baiyang Biotech Park investment to 1.061 billion yuan to expand yeast protein capacity.
Read original ↗
财中社·10dRead more →
© 2026 MarketDXNews